Benzalphthalide

CAS No. 575-61-1

Benzalphthalide( NSC 2824 | NSC-2824 | NSC2824 )

Catalog No. M27278 CAS No. 575-61-1

Benzalphthalide is a chemical compound with anti-HIV activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Benzalphthalide
  • Note
    Research use only, not for human use.
  • Brief Description
    Benzalphthalide is a chemical compound with anti-HIV activity.
  • Description
    Benzalphthalide is a chemical compound with anti-HIV activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 2824 | NSC-2824 | NSC2824
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    KRAS G12C
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    575-61-1
  • Formula Weight
    222.243
  • Molecular Formula
    C15H10O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (224.98 mM)
  • SMILES
    O=C1O\C(=C/c2ccccc2)c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nakayama A, et al. Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models. Br J Cancer. 2021 Nov 18.
molnova catalog
related products
  • CX 04328

    CX 04328 (LEDGIN-6) is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction with IC50 of 1.37 uM.

  • BMS-707035

    BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.

  • Fostemsavir Tris

    Fostemsavir Tris is the prodrug of BMS-626529,is a oral, safe and effective?inhibitor of HIV-1 attachment.?It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and interfering with the attachment of virus to CD4+ T-cells.